Lancet peer-reviewed study endorses Russia’s Sputnik V Covid-19 vaccine

Sputnik V uses two adenoviruses, AD 5 and AD 26, that target the spike protein of the SARS Cov2 virus. Companies such as AstraZeneca, Johnson & Johnson and CanSino are using one of these two vectors for their vaccines.